EX-99.3 4 d856441dex993.htm EX-99.3 EX-99.3

Exhibit 99.3

 

 

LOGO

NUTRIEN LTD.

INTERIM FINANCIAL STATEMENTS AND NOTES

AS AT AND FOR THE THREE AND NINE MONTHS ENDED

SEPTEMBER 30, 2024

 

 

 


Unaudited  

 

Condensed Consolidated Financial Statements

Condensed Consolidated Statements of Earnings

 

           Three Months Ended
September 30
    Nine Months Ended
September 30
 
 (millions of US dollars, except as otherwise noted)    Note     2024     2023     2024     2023  

 SALES

     2, 11       5,348       5,631       20,893       23,392  

 Freight, transportation and distribution

       263       263       741       714  

 Cost of goods sold

             3,585       3,741       14,203       15,972  

 GROSS MARGIN

       1,500       1,627       5,949       6,706  

 Selling expenses

       820       799       2,622       2,548  

 General and administrative expenses

       156       151       468       453  

 Provincial mining taxes

       74       96       210       319  

 Share-based compensation expense (recovery)

       1       42       17       (7

 Impairment of assets

     3       -       -       530       698  

 Foreign exchange loss, net of related derivatives

     6       31       87       359       105  

 Other expenses

     4       222       67       284       138  

 EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES

 

    196       385       1,459       2,452  

 Finance costs

             184       206       525       580  

 EARNINGS BEFORE INCOME TAXES

       12       179       934       1,872  

 Income tax (recovery) expense

     5       (13     97       352       766  

 NET EARNINGS

             25       82       582       1,106  

 Attributable to

          

 Equity holders of Nutrien

       18       75       561       1,086  

 Non-controlling interest

             7       7       21       20  

 NET EARNINGS

             25       82       582       1,106  

 NET EARNINGS PER SHARE ATTRIBUTABLE TO EQUITY HOLDERS OF NUTRIEN (“EPS”)

 

               

 Basic

       0.04       0.15       1.13       2.18  

 Diluted

             0.04       0.15       1.13       2.18  

 Weighted average shares outstanding for basic EPS

       494,743,000       494,517,000       494,653,000       496,999,000  

 Weighted average shares outstanding for diluted EPS

             494,857,000       495,056,000       494,851,000       497,708,000  
Condensed Consolidated Statements of Comprehensive Income (Loss)

 

         Three Months Ended
September 30
    Nine Months Ended
September 30
 
 (millions of US dollars, net of related income taxes)           2024     2023     2024     2023  

 NET EARNINGS

       25       82       582       1,106  

 Other comprehensive income (loss)

          

 Items that will not be reclassified to net earnings:

          

 Net actuarial loss on defined benefit plans

       -       -       -       (3

 Net fair value gain (loss) on investments

       35       (6     53       5  

 Items that have been or may be subsequently reclassified to net earnings:

          

 Gain (loss) on currency translation of foreign operations

       85       (64     28       (14

 Other

             2       (16     (17     (4

 OTHER COMPREHENSIVE INCOME (LOSS)

             122       (86     64       (16

 COMPREHENSIVE INCOME (LOSS)

             147       (4     646       1,090  

 Attributable to

          

 Equity holders of Nutrien

       139       (11     625       1,070  

 Non-controlling interest

             8       7       21       20  

 COMPREHENSIVE INCOME (LOSS)

             147       (4     646       1,090  

(See Notes to the Condensed Consolidated Financial Statements)

 

24


Unaudited  

 

Condensed Consolidated Statements of Cash Flows

 

            Three Months Ended
September 30
     Nine Months Ended
September 30
 
 (millions of US dollars)    Note      2024      2023      2024      2023  
                   Note 1             Note 1  

 OPERATING ACTIVITIES

              

 Net earnings

        25        82        582        1,106  

 Adjustments for:

              

 Depreciation and amortization

        598        552        1,749        1,604  

 Share-based compensation expense (recovery)

        1        42        17        (7

 Impairment of assets

     3        -        -        530        698  

 (Recovery of) provision for deferred income tax

        (36      55        15        176  

 Net (undistributed) distributed earnings of equity-accounted investees

        (24      (28      14        112  

 Fair value adjustment to derivatives

     6        (180      (27      6        5  

 Loss related to financial instruments in Argentina

     4        -        -        34        92  

 Long-term income tax receivables and payables

        9        1        17        (89

 Other long-term assets, liabilities and miscellaneous

              251        53        321        39  

 Cash from operations before working capital changes

        644        730        3,285        3,736  

 Changes in non-cash operating working capital:

              

 Receivables

        418        627        (2,394      (1,491

 Inventories and prepaid expenses and other current assets

        373        794        2,265        3,366  

 Payables and accrued charges

              (2,343      (2,620      (2,744      (4,695

 CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES

              (908      (469      412        916  

 INVESTING ACTIVITIES

              

 Capital expenditures 1

        (529      (634      (1,449      (1,890

 Business acquisitions, net of cash acquired

        (2      -        (6      (116

 (Purchase of) proceeds from investments, held within three months, net

        (15      (36      (30      (134

 Purchase of investments

        (1      (12      (112      (12

 Net changes in non-cash working capital

        30        36        (55      (68

 Other

              11        (27      38        (5

 CASH USED IN INVESTING ACTIVITIES

              (506      (673      (1,614      (2,225

 FINANCING ACTIVITIES

              

 Proceeds from (repayment of) debt, maturing within three months, net

        1,378        1,445        1,089        2,213  

 Proceeds from debt

     8        -        -        998        1,500  

 Repayment of debt

        (43      (118      (132      (635

 Repayment of principal portion of lease liabilities

        (98      (91      (300      (278

 Dividends paid to Nutrien’s shareholders

        (268      (261      (795      (770

 Repurchase of common shares

     9        (50      -        (50      (1,047

 Issuance of common shares

        7        1        16        32  

 Other

              (4      -        (40      (34

 CASH PROVIDED BY FINANCING ACTIVITIES

              922        976        786        981  

 EFFECT OF EXCHANGE RATE CHANGES ON CASH AND
CASH EQUIVALENTS

              8        (17      (5      (19

 DECREASE IN CASH AND CASH EQUIVALENTS

        (484      (183      (421      (347

 CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD

              1,004        737        941        901  

 CASH AND CASH EQUIVALENTS – END OF PERIOD

              520        554        520        554  

 Cash and cash equivalents is composed of:

              

 Cash

                472                508                472                508  

 Short-term investments

              48        46        48        46  

              520        554        520        554  

 SUPPLEMENTAL CASH FLOWS INFORMATION

              

 Interest paid

        148        137        496        462  

 Income taxes paid

        127        133        260        1,722  

 Total cash outflow for leases

              134        125        418        373  

 1  Includes additions to property, plant and equipment, and intangible assets for the three months ended September 30, 2024 of $489 million and $40 million (2023 – $580 million and $54 million), respectively, and for the nine months ended September 30, 2024 of $1,333 million and $116 million (2023 – $1,734 million and $156 million), respectively.

(See Notes to the Condensed Consolidated Financial Statements)

 

25


Unaudited  

Condensed Consolidated Statements of Changes in Shareholders’ Equity

 

                      Accumulated Other Comprehensive
(Loss) Income (“AOCI”)
                         
 (millions of US dollars, inclusive of related tax, except as
otherwise noted)
  Number of
Common
Shares
    Share
Capital
    Contributed
Surplus
    (Loss) Gain
on Currency
Translation
of Foreign
Operations
    Other     Total
AOCI
    Retained
Earnings
   

Equity
Holders
of

Nutrien

    Non-
Controlling
Interest
    Total
Equity
 
           

 BALANCE – DECEMBER 31, 2022

    507,246,105       14,172       109       (374     (17     (391     11,928       25,818       45       25,863  
           

 Net earnings

    -       -       -       -       -       -       1,086       1,086       20       1,106  
           

 Other comprehensive loss

    -       -       -       (14     (2     (16     -       (16     -       (16
           

 Shares repurchased (Note 9)

    (13,378,189     (374     (26     -       -       -       (600     (1,000     -       (1,000
           

 Dividends declared - $1.59/share

    -       -       -       -       -       -       (789     (789     -       (789
           

 Non-controlling interest transactions

    -       -       -       -       -       -       -       -       (14     (14
           

 Effect of share-based compensation including issuance of common shares

    664,230       39       (1     -       -       -       -       38       -       38  
           

 Transfer of net gain on sale of investment

    -       -       -       -       (14     (14     14       -       -       -  
           

 Transfer of net loss on cash flow hedges

    -       -       -       -       8       8       -       8       -       8  
           

 Transfer of net actuarial loss on defined benefit plans

    -       -       -       -       3       3       (3     -       -       -  
           

 BALANCE – SEPTEMBER 30, 2023

    494,532,146       13,837       82       (388     (22     (410     11,636       25,145       51       25,196  
           

 BALANCE – DECEMBER 31, 2023

    494,551,730       13,838       83       (286     (10     (296     11,531       25,156       45       25,201  
           

 Net earnings

    -       -       -       -       -       -       561       561       21       582  
           

 Other comprehensive income

    -       -       -       28       36       64       -       64       -       64  
           

 Shares repurchased (Note 9)

    (1,039,185     (29     (21     -       -       -       (1     (51     -       (51
           

 Dividends declared - $1.62/share

    -       -       -       -       -       -       (800     (800     -       (800
           

 Non-controlling interest transactions

    -       -       -       -       -       -       -       -       (26     (26
           

 Effect of share-based compensation including issuance of common shares

    369,904       18       5       -       -       -       -       23       -       23  
           

 Transfer of net loss on cash flow hedges

    -       -       -       -       13       13       -       13       -       13  
         

 BALANCE – SEPTEMBER 30, 2024

    493,882,449       13,827       67       (258     39       (219     11,291       24,966       40       25,006  

 (See Notes to the Condensed Consolidated Financial Statements)

 

26


Unaudited  

 

Condensed Consolidated Balance Sheets

 

          September 30            December 31  
 As at (millions of US dollars)    Note        2024          2023              2023  

 ASSETS

             

 Current assets

             

Cash and cash equivalents

        520        554          941  

Receivables

   6, 7, 11      7,786        7,713          5,398  

Inventories

        4,890        5,169          6,336  

Prepaid expenses and other current assets

          678        656          1,495  
        13,874        14,092          14,170  

 Non-current assets

             

Property, plant and equipment

   3      22,329        22,150          22,461  

Goodwill

        12,122        12,078          12,114  

Intangible assets

   3      1,877        2,219          2,217  

Investments

        739        731          736  

Other assets

          970        959          1,051  

 TOTAL ASSETS

          51,911        52,229          52,749  

 LIABILITIES

             

 Current liabilities

             

Short-term debt

   7      2,967        4,354          1,815  

Current portion of long-term debt

   8      1,013        -          512  

Current portion of lease liabilities

        364        305          327  

Payables and accrued charges

   6      6,613        6,653          9,467  
        10,957        11,312          12,121  

 Non-current liabilities

             

Long-term debt

   8      9,383        9,427          8,913  

Lease liabilities

        1,029        901          999  

Deferred income tax liabilities

        3,555        3,631          3,574  

Pension and other post-retirement benefit liabilities

        245        241          252  

Asset retirement obligations and accrued environmental costs

        1,564        1,353          1,489  

Other non-current liabilities

          172        168          200  

 TOTAL LIABILITIES

          26,905        27,033          27,548  

 SHAREHOLDERS’ EQUITY

             

Share capital

   9      13,827        13,837          13,838  

Contributed surplus

        67        82          83  

Accumulated other comprehensive loss

        (219      (410        (296

Retained earnings

          11,291        11,636          11,531  

Equity holders of Nutrien

        24,966        25,145          25,156  

Non-controlling interest

          40        51          45  

 TOTAL SHAREHOLDERS’ EQUITY

          25,006        25,196          25,201  

 TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

          51,911        52,229          52,749  

(See Notes to the Condensed Consolidated Financial Statements)

 

27


Unaudited  

 

Notes to the Condensed Consolidated Financial Statements

As at and for the Three and Nine Months Ended September 30, 2024

Note 1 Basis of presentation

Nutrien Ltd. (collectively with its subsidiaries, “Nutrien”, “we”, “us”, “our” or “the Company”) is a leading global provider of crop inputs and services. Nutrien plays a critical role in helping growers around the globe increase food production.

These unaudited interim condensed consolidated financial statements (“interim financial statements”) are based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, “Interim Financial Reporting”. The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2023 annual audited consolidated financial statements, as well as any amended standards adopted in 2024 that we previously disclosed. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2023 annual audited consolidated financial statements. Certain immaterial 2023 figures have been reclassified in the condensed consolidated statements of earnings, condensed consolidated statements of cash flows and Note 4 Other expenses (income).

In management’s opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year. These interim financial statements were authorized for issue by the Audit Committee of the Board of Directors for issue on November 6, 2024.

Note 2 Segment information

We have four reportable operating segments: Nutrien Ag Solutions (“Retail”), Potash, Nitrogen and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed and merchandise. Retail provides services directly to growers through a network of farm centers in North America, South America and Australia. The Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each produces. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

 

             
 (millions of US dollars)   Retail      Potash      Nitrogen      Phosphate     

 

Corporate
and Others

     Eliminations     Consolidated  

 Assets – as at September 30, 2024

    22,585        13,686        11,303        2,412        2,443        (518     51,911  

 Assets – as at December 31, 2023

    23,056        13,571        11,466        2,438        2,818        (600     52,749  

 

28


Unaudited  

 

    Three Months Ended September 30, 2024  
 (millions of US dollars)   Retail     Potash     Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales  – third party

    3,271       915       753       409       -       -       5,348  

        – intersegment

    -       113       163       58       -       (334     -  

 Sales  – total

    3,271       1,028       916       467       -       (334     5,348  

 Freight, transportation and distribution

    -       144       123       55       -       (59     263  

 Net sales

    3,271       884       793       412       -       (275     5,085  

 Cost of goods sold

    2,412       422       581       383       -       (213     3,585  

 Gross margin

    859       462       212       29       -       (62     1,500  

 Selling expenses (recovery)

    815       3       8       1       (2     (5     820  

 General and administrative expenses

    51       5       6       4       90       -       156  

 Provincial mining taxes

    -       74       -       -       -       -       74  

 Share-based compensation expense

    -       -       -       -       1       -       1  

 Impairment of assets

    -       -       -       -       -       -       -  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       31       -       31  

 Other expenses (income)

    32       2       (25     10       194       9       222  

 Earnings (loss) before finance costs and income taxes

    (39     378       223       14       (314     (66     196  

 Depreciation and amortization

    190       177       132       75       24       -       598  

 EBITDA

    151       555       355       89       (290     (66     794  

 Share-based compensation expense

    -       -       -       -       1       -       1  

 ARO/ERL related expense for non-operating sites

    -       -       -       -       184       -       184  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       31       -       31  

 Adjusted EBITDA

    151       555       355       89       (74     (66     1,010  
    Three Months Ended September 30, 2023  
 (millions of US dollars)   Retail     Potash     Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales  – third party

    3,489       1,002       690       450       -       -       5,631  

        – intersegment

    1       108       138       66       -       (313     -  

 Sales  – total

    3,490       1,110       828       516       -       (313     5,631  

 Freight, transportation and distribution

    -       138       105       72       -       (52     263  

 Net sales

    3,490       972       723       444       -       (261     5,368  

 Cost of goods sold

    2,595       389       569       417       -       (229     3,741  

 Gross margin

    895       583       154       27       -       (32     1,627  

 Selling expenses (recovery)

    798       3       8       1       (3     (8     799  

 General and administrative expenses

    57       2       1       3       88       -       151  

 Provincial mining taxes

    -       96       -       -       -       -       96  

 Share-based compensation expense

    -       -       -       -       42       -       42  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       87       -       87  

 Other expenses (income)

    37       4       (19     8       30       7       67  

 Earnings (loss) before finance costs and income taxes

    3       478       164       15       (244     (31     385  

 Depreciation and amortization

    189       133       130       75       25       -       552  

 EBITDA

    192       611       294       90       (219     (31     937  

 Integration and restructuring related costs

    5       -       -       -       9       -       14  

 Share-based compensation expense

    -       -       -       -       42       -       42  

 ARO/ERL related expense for non-operating sites

    -       -       -       -       4       -       4  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       87       -       87  

 Adjusted EBITDA

    197       611       294       90       (77     (31     1,084  

 

29


Unaudited  

 

    Nine Months Ended September 30, 2024  
 (millions of US dollars)   Retail     Potash     Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales  – third party

    14,653       2,486       2,547       1,207       -       -       20,893  

        – intersegment

    -       305       584       210       -       (1,099     -  

 Sales  – total

    14,653       2,791       3,131       1,417       -       (1,099     20,893  

 Freight, transportation and distribution

    -       338       399       174       -       (170     741  

 Net sales

    14,653       2,453       2,732       1,243       -       (929     20,152  

 Cost of goods sold

    11,018       1,139       1,835       1,116       -       (905     14,203  

 Gross margin

    3,635       1,314       897       127       -       (24     5,949  

 Selling expenses (recovery)

    2,610       9       23       5       (7     (18     2,622  

 General and administrative expenses

    154       10       16       11       277       -       468  

 Provincial mining taxes

    -       210       -       -       -       -       210  

 Share-based compensation expense

    -       -       -       -       17       -       17  

 Impairment of assets

    335       -       195       -       -       -       530  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       359       -       359  

 Other expenses (income)

    95       3       (136     26       274       22       284  

 Earnings (loss) before finance costs and income taxes

    441       1,082       799       85       (920     (28     1,459  

 Depreciation and amortization

    580       475       419       213       62       -       1,749  

 EBITDA

    1,021       1,557       1,218       298       (858     (28     3,208  

 Share-based compensation expense

    -       -       -       -       17       -       17  

 Impairment of assets

    335       -       195       -       -       -       530  

 Loss related to financial instruments in Argentina

    -       -       -       -       34       -       34  

 ARO/ERL related expense for non-operating sites 

    -       -       -       -       152       -       152  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       359       -       359  

 Adjusted EBITDA

    1,356       1,557       1,413       298       (296     (28     4,300  
    Nine Months Ended September 30, 2023  
 (millions of US dollars)   Retail     Potash     Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales  – third party

    16,038       3,001       2,909       1,444       -       -       23,392  

       – intersegment

    2       302       708       204       -       (1,216     -  

 Sales  – total

    16,040       3,303       3,617       1,648       -       (1,216     23,392  

 Freight, transportation and distribution

    -       320       366       188       -       (160     714  

 Net sales

    16,040       2,983       3,251       1,460       -       (1,056     22,678  

 Cost of goods sold

    12,599       1,047       2,157       1,297       -       (1,128     15,972  

 Gross margin

    3,441       1,936       1,094       163       -       72       6,706  

 Selling expenses

    2,534       9       23       5       (7     (16     2,548  

 General and administrative expenses

    162       10       11       10       260       -       453  

 Provincial mining taxes

    -       319       -       -       -       -       319  

 Share-based compensation recovery

    -       -       -       -       (7     -       (7

 Impairment of assets

    465       -       -       233       -       -       698  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       105       -       105  

 Other expenses (income)

    81       2       (53     21       82       5       138  

 Earnings (loss) before finance costs and income taxes

    199       1,596       1,113       (106     (433     83       2,452  

 Depreciation and amortization

    558       345       426       213       62       -       1,604  

 EBITDA

    757       1,941       1,539       107       (371     83       4,056  

 Integration and restructuring related costs

    8       -       -       -       21       -       29  

 Share-based compensation recovery

    -       -       -       -       (7     -       (7

 Impairment of assets

    465       -       -       233       -       -       698  

 Loss related to financial instruments in Argentina

    -       -       -       -       92       -       92  

 ARO/ERL related expense for non-operating sites

    -       -       -       -       10       -       10  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       105       -       105  

 Adjusted EBITDA

    1,230       1,941       1,539       340       (150     83       4,983  

 

30


Unaudited  

 

    Three Months Ended
September 30
    Nine Months Ended
September 30
 
 (millions of US dollars)   2024     2023     2024     2023  

 Retail sales by product line

       

Crop nutrients

    1,093       1,250       5,683       6,571  

Crop protection products

    1,518       1,566       5,365       5,790  

Seed

    132       158       2,051       2,093  

Services and other

    242       235       690       691  

Merchandise

    222       231       667       750  

Nutrien Financial

    85       73       284       252  

Nutrien Financial elimination 1

    (21     (23     (87     (107
      3,271       3,490       14,653       16,040  

 Potash sales by geography

       

Manufactured product

       

North America

    601       637       1,474       1,631  

Offshore 2

    427       473       1,316       1,672  

Other potash and purchased products

    -       -       1       -  
      1,028       1,110       2,791       3,303  

 Nitrogen sales by product line

       

Manufactured product

       

Ammonia

    261       193       856       998  

Urea and ESN®

    293       297       1,085       1,278  

Solutions, nitrates and sulfates

    299       270       961       1,022  

Other nitrogen and purchased products

    63       68       229       319  
      916       828       3,131       3,617  

 Phosphate sales by product line

       

Manufactured product

       

Fertilizer

    316       295       928       886  

Industrial and feed

    148       151       470       535  

Other phosphate and purchased products

    3       70       19       227  
      467       516       1,417       1,648  

1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

2 Relates to Canpotex Limited (“Canpotex”) (Note 11) and includes provisional pricing adjustments for the three months ended September 30, 2024 of $(4) million (2023 – $(34) million) and the nine months ended September 30, 2024 of $7 million (2023 – $(354) million).

Note 3 Impairment of assets

We recorded the following non-cash impairment of assets in the condensed consolidated statements of earnings:

 

         Nine Months Ended
September 30
 
 (millions of US dollars)         2024     2023  

Segment

   Category    

 Retail

   Intangible assets     200         43   
   Property, plant and equipment     120         -   
   Other     15         -   
   Goodwill     -         422   

 Nitrogen

   Property, plant and equipment     195         -   

 Phosphate

  

Property, plant and equipment

    -         233   

 Impairment of assets

    530         698   

Retail – Brazil

At June 30, 2024, due to the ongoing market instability and more moderate margin expectations, we lowered our forecasted EBITDA for the Retail – Brazil cash generating unit (“CGU”). This triggered an impairment analysis. Prior to June 30, 2023, the Retail – Brazil CGU was part of the Retail – South America group of CGUs at which time the goodwill of the group was deemed to be fully impaired.

We used the fair value less cost to dispose (“FVLCD”) methodology (level 3) based on a market approach to assess the recoverable value of the Retail – Brazil CGU at June 30, 2024. This is a change from our 2023 analysis, as the market approach resulted in a more representative fair value of the CGU as restructuring initiatives in Brazil are currently being developed. In 2023, we used the

 

31


Unaudited  

 

FVLCD methodology based on after-tax discounted cash flows (10-year projections plus a terminal value) and an after-tax discount rate (14.4 percent). We incorporated assumptions that an independent market participant would apply.

The key assumptions with the greatest influence on the calculation of the impairment are the estimated recoverable value of property, plant and equipment and intangible assets. Any change to these estimates could directly impact the impairment amount.

 

 (millions of US dollars)    Retail – Brazil
June 30, 2024
 

 Recoverable amount comprised of:

  

Working capital and other

     324  

Property, plant and equipment

     92  

Intangible assets

     -  

Nitrogen

During the three months ended June 30, 2024, we decided that we are no longer pursuing our Geismar Clean Ammonia project. As a result, we recorded an impairment loss of $195 million to fully write-off the amount of property, plant and equipment related to this project. As the project was cancelled before it generated revenue, the recoverable amount, which was based on its value in use, is $nil.

At June 30, 2023, we recorded an impairment of $465 million on our Retail – South America groups of CGUs and $233 million on our Phosphate – White Springs CGU. Refer to Note 13 of our 2023 annual audited consolidated financial statements for further details.

Note 4 Other expenses (income)

 

     Three Months Ended
September 30
     Nine Months Ended
September 30
 
 (millions of US dollars)        2024          2023          2024          2023  

 Integration and restructuring related costs

     -         14         -         29   

 Earnings of equity-accounted investees

     (26      (28      (107      (100

 Bad debt expense

     31         12         94         51   

 Project feasibility costs

     19         19         62         53   

 Customer prepayment costs

     10         10         41         36   

 Insurance recoveries

     (3      -         (70      -   

 Loss on natural gas derivatives not designated as hedge ¹

     5         -         7         -   

 Loss related to financial instruments in Argentina

     -         -         34         92   

 ARO/ERL related expenses for non-operating sites ²

     184         4         152         10   

 Gain on amendments to other post-retirement pension plans

     -         -         -         (80

 Other expenses

     2         36         71         47   
       222         67         284         138   

1 Includes realized loss of $3 million and $5 million for the three and nine months ended September 30, 2024 (2023 – $nil) and unrealized loss of $2 million for the three and nine months ended September 30, 2024, respectively (2023 – $nil).

2 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

Argentina has certain currency controls in place that limit our ability to settle our foreign currency-denominated obligations or remit cash out of Argentina. We utilize various financial instruments such as Blue Chip Swaps or Bonds for the Reconstruction of a Free Argentina (“BOPREAL”) that effectively allow companies to transact in US dollars. We incurred losses on these transactions due to the significant divergence between the market exchange rate used for these financial instruments and the official Central Bank of Argentina rate. These losses are recorded as part of loss related to financial instruments in Argentina.

Note 5 Income taxes

A separate estimated average annual effective income tax rate was determined and applied individually to the interim period pre-tax earnings for each taxing jurisdiction.

 

     Three Months Ended
September 30
     Nine Months Ended
September 30
 
 (millions of US dollars, except as otherwise noted)        2024          2023          2024          2023  

 Actual effective tax rate on earnings (%)

     (18      41         41         33   

 Actual effective tax rate including discrete items (%)

     (112      54         38         41   

 Discrete tax adjustments that impacted the tax rate

     (11      23         (31      155   

 

32


Unaudited  

 

Note 6 Financial instruments

Foreign Currency Derivatives

 

     Three Months Ended
September 30
     Nine Months Ended
September 30
 
 (millions of US dollars)        2024          2023          2024          2023  

 Foreign exchange (gain) loss

     (3      32         27         12   

 Hyperinflationary loss

      20         46          85         78   

 Loss on foreign currency derivatives at fair value through profit or loss

     14        9         247         15   

 Foreign exchange loss, net of related derivatives

     31        87         359         105   

During the nine months ended September 30, 2024, we entered into various foreign currency derivative contracts. The losses on our foreign currency derivatives were primarily related to Brazil which matured in July 2024. As of September 30, 2024, outstanding derivative contracts were related to our ongoing risk management strategy. The fair value of our net foreign exchange currency derivative assets (liabilities) as at September 30, 2024 was $3 million (December 31, 2023 – $11 million).

 

     As at September 30, 2024      As at December 31, 2023  
 (millions of US dollars, except as
otherwise noted)
   Notional      Maturities
(year)
     Average
Contract
Rate
(1:1)
     Notional      Maturities
(year)
     Average
Contract
Rate
(1:1)
 

 Derivatives not designated as hedges

                 

Forwards (Sell/buy)

                 

USD/Canadian dollars (“CAD”)

     416        2024        1.3445        435        2024        1.3207   

Brazilian real (“BRL”)/USD

     213        2024        5.4668        94        2024        4.8688   

Australian dollars (“AUD”)/USD

     75        2025        1.4940        86        2024        1.5269   

USD/BRL

     94        2025        5.5408        -        -        -   

USD/BRL

     58        2025        5.6617        -        -        -   

USD/AUD

     11        2024        1.4904        -        -        -   

 Derivatives designated as hedges

                 

Forwards (Sell/buy)

                 

USD/CAD

     485        2025        1.3638        601        2024        1.3565   

Natural Gas Derivatives

In 2024, we increased our use of natural gas derivatives to lock-in commodity prices. Our risk management strategies and accounting policies for derivatives that are designated and qualify as cash flow hedges are consistent with those disclosed in Note 10 and Note 30 of our annual consolidated financial statements, respectively. For derivatives that do not qualify as cash flow hedges, any gains or losses are recorded in net earnings in the current period.

We assess whether our derivative hedging transactions are expected to be or were highly effective, both at the hedge’s inception and on an ongoing basis, in offsetting changes in fair values of hedged items.

 

Hedging Transaction  

     Measurement of Ineffectiveness           

Potential Sources of Ineffectiveness

New York Mercantile Exchange (“NYMEX”) natural gas hedges      Assessed on a prospective and retrospective basis using regression analyses     

Changes in:

 timing of forecast transactions

 volume delivered

 our credit risk or the credit risk of a counterparty

 

33


Unaudited  

 

The table below presents information about our natural gas derivatives which are used to manage the risk related to significant price changes in natural gas.

 

    As at September 30, 2024  
 (millions of US dollars, except as otherwise noted)   Notional 1     Maturities
(year)
    Average
Contract Price 2
   

Fair Value of
Assets (Liabilities) 3

 

 Derivatives not designated as hedges

       

NYMEX call options

    15       2024       3.15       1  

 Derivatives designated as hedges

       

NYMEX swaps

    12       2024       3.06       (1

 1  In millions of Metric Million British Thermal Units (“MMBtu”).

 2  US dollars per MMBtu.

 3  Fair value of natural gas derivatives are based on a discounted cash flow model which are classified as Level 2.

Our financial instruments carrying amount are a reasonable approximation of their fair values, except for our long-term debt that has a carrying value of $10,396 million and fair value of $10,194 million as at September 30, 2024. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

Note 7 Short-term debt

On March 7, 2024, we entered into an uncommitted $500 million accounts receivable repurchase facility (the “repurchase facility”), where we may sell certain receivables from customers to a financial institution and agree to repurchase those receivables at a future date. When we draw under this repurchase facility, the receivables from customers remain on our condensed consolidated balance sheet as we control and retain substantially all of the risks and rewards associated with the receivables. As at September 30, 2024, there were no borrowings outstanding under this facility.

During the three months ended September 30, 2024, we extended the term of our unsecured revolving term credit facility to September 3, 2025 and reduced the facility limit from $1,500 million to $750 million. We also extended the maturity of our $4,500 million unsecured revolving term facility to September 4, 2029.

Note 8 Long-term debt

 

 Issuances in the nine months ended September 30, 2024

 

(millions of US dollars, except as otherwise noted)

   Rate of interest (%)         Maturity         Amount   

 Senior notes issued 2024

     5.2           June 21, 2027           400   

 Senior notes issued 2024

     5.4           June 21, 2034           600   
                             1,000   

The notes issued in the nine months ended September 30, 2024, are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

In March 2024, we filed a base shelf prospectus in Canada and the US qualifying the issuance of common shares, debt securities and other securities during a period of 25 months from March 22, 2024.

Note 9 Share capital

Share Repurchase Programs

The following table summarizes our share repurchase activities during the periods indicated below:

 

     Three Months Ended
September 30
     Nine Months Ended
September 30
 
 (millions of US dollars, except as otherwise noted)    2024       2023       2024       2023   

 Number of common shares repurchased for cancellation

     1,039,185         -         1,039,185         13,378,189   

 Average price per share (US dollars)

     48.11         -         48.11         74.73   

 Total cost, inclusive of tax

     51         -         51         1,000   

As of November 5, 2024, an additional 477,671 common shares were repurchased for cancellation at a cost of $23 million and an average price per share of $48.68.

 

34


Unaudited  

 

Note 10 Seasonality

Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. The results of this seasonality have a corresponding effect on receivables from customers and rebates receivables, inventories, prepaid expenses and other current assets, and trade payables. Our short-term debt also fluctuates during the year to meet working capital requirements. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

Note 11 Related party transactions

We sell potash outside Canada and the US exclusively through Canpotex. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed upon prices. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex.

 

 As at (millions of US dollars)      September 30, 2024         December 31, 2023   

 Receivables from Canpotex

     195         162   

Note 12 Accounting policies, estimates and judgments

IFRS 18, “Presentation and Disclosure in Financial Statements” (“IFRS 18”), which was issued on April 9, 2024, would supersede IAS 1, “Presentation of Financial Statements” and increase the comparability of financial statements by enhancing principles on aggregation and disaggregation. IFRS 18 will be effective January 1, 2027, and will also apply to comparative information. We are reviewing the standard to determine the potential impact.

Amendments for IFRS 9 and IFRS 7, “Amendments to the Classification and Measurement of Financial Instruments”, which was issued on May 30, 2024, will address diversity in practice by making the requirements more understandable and consistently applied. These amendments will be effective January 1, 2026, and will not apply to comparative information. We are reviewing the standard to determine the potential impact.

 

35